Virtus ETF Advisers’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,052
| Closed | -$66K | – | 494 |
|
|
2022
Q1 | $66K | Sell |
12,052
-721
| -6% | -$3.95K | 0.03% | 356 |
|
|
2021
Q4 | $124K | Buy |
12,773
+5,295
| +71% | +$51.4K | 0.05% | 369 |
|
|
2021
Q3 | $134K | Sell |
7,478
-390
| -5% | -$6.99K | 0.06% | 361 |
|
|
2021
Q2 | $192K | Sell |
7,868
-26,528
| -77% | -$647K | 0.08% | 369 |
|
|
2021
Q1 | $911K | Buy |
34,396
+603
| +2% | +$16K | 0.38% | 96 |
|
|
2020
Q4 | $256K | Sell |
33,793
-17,070
| -34% | -$129K | 0.11% | 305 |
|
|
2020
Q3 | $255K | Sell |
50,863
-6,930
| -12% | -$34.7K | 0.13% | 258 |
|
|
2020
Q2 | $346K | Buy |
+57,793
| New | +$346K | 0.16% | 268 |
|